We are live on ! Find out more
MPA

Marvin & Palmer Associates Portfolio holdings

AUM $159M
1-Year Est. Return 109.02%
This Fund
S&P 500
This Quarter Est. Return
+1.46%
1 Year Est. Return
+109.02%
3 Year Est. Return
+392.2%
5 Year Est. Return
+719.89%
10 Year Est. Return
+4,985%
AUM
$163M
AUM Growth
-$31.4M
Cap. Flow
-$26.2M
Cap. Flow %
-16.06%
Top 10 Hldgs %
55.25%
Holding
39
New
12
Increased
2
Reduced
8
Closed
14

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$9.11M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$8.22M
3
SNPS icon
Synopsys
SNPS
+$8.01M
4
AMP icon
Ameriprise Financial
AMP
+$7.89M
5
MS icon
Morgan Stanley
MS
+$7.49M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$10.3M
2
MRK icon
Merck
MRK
+$9.66M
3
COP icon
ConocoPhillips
COP
+$9.3M
4
CB icon
Chubb
CB
+$9.04M
5
LIN icon
Linde
LIN
+$8.55M

Sector Composition

Rank Sector Weight
1 Financials 24.78%
2 Healthcare 22.52%
3 Technology 17.36%
4 Industrials 16.08%
5 Consumer Discretionary 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMO icon
26
Bank of Montreal
BMO
$127B
-69,658
Closed -$6.7M
BMY icon
27
Bristol-Myers Squibb
BMY
$132B
-105,500
Closed -$8.12M
CB icon
28
Chubb
CB
$135B
-45,989
Closed -$9.04M
CME icon
29
CME Group
CME
$94.8B
-40,015
Closed -$8.19M
COP icon
30
ConocoPhillips
COP
$141B
-103,587
Closed -$9.3M
CVX icon
31
Chevron
CVX
$366B
-52,209
Closed -$7.56M
DE icon
32
Deere & Co
DE
$168B
-25,068
Closed -$7.51M
FTNT icon
33
Fortinet
FTNT
$117B
-134,970
Closed -$7.64M
GLD icon
34
SPDR Gold Trust
GLD
$142B
-3,320
Closed -$559K
KLAC icon
35
KLA
KLAC
$259B
-233,750
Closed -$7.46M
KR icon
36
Kroger
KR
$34.8B
-160,703
Closed -$7.61M
LIN icon
37
Linde
LIN
$226B
-29,740
Closed -$8.55M
LLY icon
38
Eli Lilly
LLY
$1.06T
-31,700
Closed -$10.3M
MRK icon
39
Merck
MRK
$318B
-105,965
Closed -$9.66M

Similar funds

Marvin & Palmer Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Marvin & Palmer Associates held 39 positions worth $163M, down 16% from $194M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Marvin & Palmer Associates withdrew a net $26.2M in Q3 2022, closing 14 positions and reducing 8 holdings. Its most notable exit was Eli Lilly, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Marvin & Palmer Associates opened a new position in Goldman Sachs worth $8.24M.

  • Marvin & Palmer Associates's largest Q3 2022 buy was Goldman Sachs: 28,129 shares worth $8.24M.
  • Marvin & Palmer Associates added most to Morgan Stanley in Q3 2022, an estimated $7.49M increase.
  • Marvin & Palmer Associates's biggest Q3 2022 reduction was RTX Corp, cutting an estimated $1.57M.
  • Marvin & Palmer Associates fully exited Eli Lilly in Q3 2022, selling an estimated $10.3M.
  • Marvin & Palmer Associates's ten largest holdings make up 55% of its $163M portfolio in Q3 2022.
  • Marvin & Palmer Associates opened 12 new positions and closed 14 in Q3 2022.
  • Marvin & Palmer Associates's portfolio value fell 16% quarter-over-quarter to $163M.

Based on Marvin & Palmer Associates's 13F filing for Q3 2022, filed 14 Nov 2022.